‘Discovery’ mass spectrometer system now live in HRI’s Fluxomics Centre
The cutting-edge liquid chromatography-mass spectrometer system in HRI's Fluxomics Centre will allow researchers to deeply analyse molecular changes in CVD over time.
Leading cause of death in Australia: Heart disease insights
Heart disease remains the leading cause of death in Australia, according to figures released this week by the Australian Bureau of Statistics (ABS).
Research assistant Michael Hutton publishes review on atherosclerosis research
In HRI’s Atherosclerosis and Vascular Remodelling Group, research assistant Michael Hutton and Dr Ashish Misra have published a review on new targets in the treatment of atherosclerosis.
Dr Xuyu Liu receives Selby Research Award
Dr Xuyu Liu has received a prestigious Selby Research Award for 2023 for his research which aims to develop next-generation precision medicine.
HRI members present at CSANZ Annual Scientific Meeting
HRI members presented at the 71st CSANZ Annual Scientific Meeting, with Manisha Patil a finalist for the Ralph Reader Prize in Basic and Translational Science.
New Director of Science Strategy, Dr Mathew Vadas AO, joins HRI
HRI welcomes Dr Mathew Vadas AO as Director of Science Strategy. Dr Vadas is an internationally renowned immunologist and research leader.
PhD student Alexander Lin publishes collaborative review on atherosclerosis research
The HRI Atherosclerosis and Vascular Remodelling Group has published a paper on how cardiovascular diseases are linked to clonal expansion in JACC: Basic to Translational Science.
HRI breaking new ground in stroke research and care
Assoc Prof Simone Schoenwaelder publishes an update on the exciting advancements in stroke research at HRI that could help stroke patients.
Revolutionising new treatment options for stroke
HRI has been awarded an almost $1 million Cardiovascular Research Capacity Program grant to revolutionise treatment options for stroke.